Private Child Psychiatry

Areas of Expertise (conditions)

All types of psychiatric conditions, including anxiety and depression, psychosis, bipolar disorder, PTSD, ASD, ADHD, emerging personality disorder and attachment difficulties.

Career History

• Completed training in Core Psychiatry in East London Foundation Trust, London.
• Completed higher speciality training in Child and Adolescent Psychiatry at Tavistock and Portman.
• Has been appointed Consultant Child and Adolescent Psychiatrist in NHS

Associations

Alzbeta is currently a research associate with Centre for Understanding of Personality Disorder, a joint research programme of DeanCross Personality Disorder Service, East London Foundation NHS Trust and the Centre for Psychiatry, Wolfson Institute, Barts and The London School of Medicine & Dentistry Queen Mary University and Department of Psychiatry, Oxford University

Published papers / Media
Co-author of Transition from child and adolescent MHS to adult MHS: what happens to young people with personality disorder? Published online by Cambridge University Press:  18 June 2021

Education

• Charles University, First Faculty of Medicine Prague
• Certificate of Higher Education in Psychodynamic Counselling and Organisational Dynamics at Birkbeck College, University of London
• Postgraduate Diploma in Psychiatry, Cardiff University
• Foundation Certificate in Systemic approaches in working with individuals and families, Tavistock and Portman NHS Foundation Trust

He has a keen interest in the neurobiology and genetics of neurodevelopmental disorders, especially the fields of neuroimmunology, metabolism and the microbiome. He is very keen to help advocate and advance the translation of science into treatments for children with neurodisabling conditions, particularly within the field of Autism. 

Dr Marlow also has a keen interest in teaching and has completed a Post Graduate Certificate in Medical Education (PGCME). He is an Associate Clinical Lecturer at Anglia Ruskin University (Chelmsford)

Memberships and Editorial Boards

Member of the Royal College of Paediatrics and Child Health, British Association of Childhood Disability (BACD) and British Paediatric Neurology Association (BPNA).

Ben is a regular writer for the publication ‘Autism Eye’.

Education

Dr Marlow completed his medical training at University College London (UCL). Prior to his role as a doctor, he completed a Masters in Biochemistry and worked for GlaxoSmithKline (GSK) and UCB Pharma in Research and Development. He also completed a research fellowship at the University of Florida.

Browser doesn’t support frames

Ifi specializes in early intervention & assessment of infants and toddlers presenting with ASD symptoms or/and developmental delays. She was the first to become certified in the Early Start Denver Model (ESDM) in London and has completed the ESDM Parent Coaching Workshop. She has extensive experience in coaching, supervising, and supporting families of children with a number of different developmental difficulties and conditions. 

Areas of Expertise (conditions or services):

• Early Start Denver Model (ESDM)
• Paediatric Autism Communication Therapy (PACT)
• Parent Coaching & Training
• ASD Assessment (ADOS-2, CARS-2, 3di)
• Early Childhood Development 

Education

BSc in Psychology, Aristotle University of Thessaloniki

MSc in Child and Adolescent Mental Health, University College London

Published papers / Media:

1. 1. Mourelatou, I., Gaete, J., Fewings, S., Hickie, O., & Kyriakopoulos, M. (2019). What Was Helpful Questionnaire (WHQ): Psychometric Properties of a Novel Tool Designed to Capture Parental Perceived Helpfulness of Interventions in Children Requiring Mental Health Inpatient Care. Frontiers in psychiatry, 10, 80. https://doi.org/10.3389/fpsyt.2019.00080

Areas of Expertise (conditions)

Anxiety, Mood disorder, ADHD

Associations

GMC, Royal College of Psychiatrists

Published papers / Media 

Ardizzone, I., Nardecchia, F., Marconi, A., Carratelli, T. I., & Ferrara, M. (2010). Antipsychotic medication in adolescents suffering from schizophrenia: a meta-analysis of randomized controlled trials.
Psychopharmacol Bull, 43(2), 45-66. 

Using antipsychotic medication for the treatment of schizophrenia in children and adolescents
M Ferrin, G Helen, M Arianna, MR Joseph – … International Association for , 2016 – iacapap.org 

Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study
M Di Forti, A Marconi, E Carra, S Fraietta, A Trotta – The Lancet …, 2015 – Elsevier  

Meta-analysis of the association between the level of cannabis use and risk of psychosis
A Marconi, M Di Forti, CM Lewis… – Schizophrenia …, 2016 – academic.oup.com 

Cannabis use has been reported to induce long-lasting psychotic disorders and a dose-response relationship has been observed. We performed a systematic review of studies that investigate the association between the degree of cannabis consumption and psychosis and Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users
A Trotta, L Ferraro, SA Stilo, A Marconi- Schizophrenia …, 2014 – academic.oup.com 

Obstetric complications and early-onset schizophrenia: a case-control study
I Ardizzone, A Marconi, F Nardecchia – Rivista di Psichiatria, 2009 – europepmc.org 

Marconi, Arianna, and Ignazio Ardizzone. “Autobiographical delusion and subjectivation: problems in diagnosis and treatment during adolescence.”
Psychosis 4.1 (2012): 74-80. 

Education

Dr Marconi completed her medical training with distinction in one of the best universities in Italy, “La Sapienza” University of Rome. During her 5-year post-graduate program, she was awarded with an honorary placement where she completed a mixed research/clinical attachment at the Institute of Psychiatry, King’s College of London. In this context, she was involved in several European Research projects about gene-environment interplay in the etiology of psychosis.

Dr Ferrin has been providing tailored medical treatments and non-pharmacological approaches including CBT and psychoeducation to these patients and their families.

Dr Ferrin has published more than 40 international peer-reviewed articles and book chapters in the field of child psychiatry. She is part of the steering committee of the Continuum ADHD Project, an expert-led pan-European educational initiative in the ADHD field. Dr Ferrin is also one of the few UK members of the Eunethydis Group (European Network for Hyperkinetic Disorders) and the European ADHD Guidelines Group (EAGG), independent international leading groups with special clinical and research interest in the ADHD/ADD field

Education

Dr Ferrin graduated from University of Navarre (Spain) in 2001 and subsequently completed her training in General Psychiatry in Pamplona, Spain, and then undertook specialist fellowship training in Child and Adolescent Psychiatry at the Imperial College in London. In 2005-2006 Dr Ferrin completed her MSc training in Child and Adolescent Mental Health at the Institute of Psychiatry, King´s College London. In 2010 she completed her European PhD in Neurosciences at the University of Granada/King´s College London, and she was qualified with the prestigious Cum Laude (equivalent to Distinction grade). During these years Dr Ferrin continued working as CAMHS Consultant Psychiatry, specialising in diagnosis and treatment of ADHD/ASD and comorbid conditions throughout the lifespan.

Dr Ferrin is Honorary Clinical Lecturer at the Brain and Behaviour Laboratory, at the University of Southampton

He served on the board of medical and scientific charities and is currently President of the Hellenic Medical Society of the UK. He regularly teaches Psychiatry of Learning Disabilities to medical students at University College London. He is currently research collaborating investigator in a study of the genetics of learning disability and a clinical trial of a novel psychotropic medication.

Since 2008 he worked as Consultant Psychiatrist for the following organisations: South London & Maudsley NHS FT, The Cambian Group and Camden and Islington NHS FT. Dr Paschos currently works for the NHS part-time where he focuses on the mental health of adults with learning and developmental disabilities. He has a special interest in ADHD, Autism Spectrum Disorders and the mental health of people with Learning Disability. He leads the Blue Sky Adult ADHD Clinic.

Education

Dr Dimitrios Paschos completed his basic medical training in the Aristotle University of Thessaloniki. He graduated in 1998 and started his specialist training as a psychiatrist in England in 1999. He trained at the South London and Maudsley. He gained experience in General Psychiatry, Old Age Psychiatry, Rehabilitation, Liaison Psychiatry, Substance Misuse, Learning Disabilities and Child and Adolescent Psychiatry. During his training he worked at Lewisham, Lambeth, Maudsley, Royal Bethlem and Guy’s Hospitals.

Dr Paschos continued his higher specialist training (SpR) in South London and Maudsley and completed his specialisation in the Psychiatry of Learning Disabilities. This included training at the National Adult ADHD Centre at the Maudsley Hospital. He holds certificate of completion of specialist training (CCT) and is on the GMC specialist register.